What Has Been the Progress and Growth of the Osteoarthritis Market in Recent Years?
The osteoarthritis market has seen considerable growth due to a variety of factors.
• In recent times, there has been a robust expansion in the osteoarthritis market size. The projection is an increase from $6.87 billion in 2024 to $7.53 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%.
The growth during the historical period is mainly due to factors like an aging population, increasing obesity rates, advancement in imaging techniques, and pain management.
What Can Be Expected from the Osteoarthritis Market Size?
The osteoarthritis market is expected to maintain its strong growth trajectory in upcoming years.
• The market scale for osteoarthritis is projected to expand significantly in the upcoming years. It is estimated to reach $10.64 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%.
Non-pharmacological strategies, disease-altering osteoarthritis medications (dmoads), customized healthcare, telemedicine, and remote supervision contribute to the anticipated growth in this forecast period. Key trends during this period will involve regenerative treatments, wearable technology, application of artificial intelligence in diagnosis, and digital health instruments.
What Are the Critical Driver Fuelling The Osteoarthritis Market's Growth?
The rise in disorders related to obesity is predicted to fuel the expansion of the osteoarthritis market. Obesity-related issues encompass various health problems that can stem from excessive body fat accumulation, which is a result of consuming more calories than the body is able to burn through physical activity and exercise, indulging in excessive processed or fast food and consuming excessive alcohol. Obesity can lead to osteoarthritis by putting undue stress on joints, causing inflammation, and altering hormonal balances, which increases the load-bearing strain on the joints. The World Obesity Atlas 2022, released by the World Obesity Federation, a non-profit organization from the UK, projects that by 2030, around 1 billion people globally, including 1 out of 7 men and 1 out of 5 women, will be suffering from obesity. By 2035, this number is expected to rise to 4 billion people or 51% of the world's population, who will be either overweight or obese. Hence, the rising rates of obesity-related disorders are a driving factor for the growth of the osteoarthritis market. One of the major factors influencing the growth of the osteoarthritis market is the extensive usage of painkillers. Painkillers, which are drugs or substances utilized to provide pain relief, work by reducing pain perception, which can help ease the discomfort associated with different conditions or damages. The comprehensive use of painkillers in managing osteoarthritis, spurred by the necessity for effective pain management, can significantly affect the osteoarthritis market. This can result in heightened demand, affect treatment protocols, incite research and development activities, and elevate awareness about the disease. A study conducted in June 2022 by the Consumer Healthcare Products Association, a trade association in the US, revealed that nearly 80% of participants reported that their consumption of over-the-counter pain relievers has either stayed the same (49%) or increased (30%) over the past two years. Hence, the broad usage of painkillers is a key driving force for the expansion of the osteoarthritis market.
How Is The Osteoarthritis Market segmented?
The osteoarthritis market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Therapy
2) By Diagnosis: Imaging, Joint Fluid Analysis
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Medical Institutes
Subsegments:
1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)
2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion
3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices
Pre-Book The Osteoarthritis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Osteoarthritis Market?
Key corporations in the osteoarthritis sector are utilizing strategic partnerships as a method to augment technological integration and widen their market influence. This strategy pertains to a cooperative relationship shared among multiple organizations aiming to pool their resources, skills, and endeavors to fulfill shared aims or goals. As an example, the South Korean pharmaceutical firm LG Chem broke into the Chinese market in July 2024 by partnering with Yifan Pharmaceutical Co., Ltd., a pharmaceutical research and production company based in China. Their collaboration led to the introduction of Synovian injection for treating osteoarthritis, offering similar therapeutic benefits to conventional multi-injection formulas but requiring only a single administration. Synovian has some unique attributes, such as its high molecular weight (10 million Dalton) hyaluronic acid, contributing to enhance viscoelasticity and joint function, along with the proven ability to significantly alleviate knee pain as per the outcomes of clinical phase 3 trials. This development establishes Synovian as an effective treatment option for patients looking for easy mitigation from the symptoms of osteoarthritis.
Who Are the Key Players In The Osteoarthritis Market?
Major companies operating in the osteoarthritis market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck Sharp & Dohme Corp.
• Abbvie Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• AstraZeneca PLC
• Abbott Laboratories Incorporation
• Eli Lilly and Company
• Boehringer Ingelheim
• Novo Nordisk A/S
• Reckitt Benckiser Group PLC
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Mylan N.V.
• Astellas Pharma Inc.
• Zimmer Biomet Holdings Inc.
• Eisai Co. Ltd.
• Horizon Therapeutics PLC
• Apotex Inc.
• Mallinckrodt Pharmaceuticals
• Pacira BioSciences Inc.
• Bioventus Inc.
• Endo Pharmaceuticals Inc.
• Assertio Therapeutics Inc.
• Anika Therapeutics Inc.
• Abiogen Pharma Spa
• Kolon TissueGene Inc.
• Ampio Pharmaceuticals Inc.
What Is The Most Dominant Region In The Osteoarthritis Market?
North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
